{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:53:00Z","timestamp":1791273180637,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","award":["Grant-ID 25067"],"award-info":[{"award-number":["Grant-ID 25067"]}],"id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.lungcan.2026.109563","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:38:55Z","timestamp":1786117135000},"page":"109563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Immune signatures in NSCLC associated pleural effusions and implications for prognosis"],"prefix":"10.1016","volume":"219","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1300-7761","authenticated-orcid":false,"given":"Matilde","family":"Lombardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gerckens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcl\u00fcmser Hale","family":"Alkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Khmelovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Gaedtke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Wei\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1223-6574","authenticated-orcid":false,"given":"Georg","family":"Mertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Kr\u00e4mer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Melzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Leuschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.\u00d6nder","family":"Yildirim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus","family":"Kneidinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Behr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1288-809X","authenticated-orcid":false,"given":"Gabriel Mircea","family":"Stoleriu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2501-3356","authenticated-orcid":false,"given":"Carlo","family":"M\u00fcmmler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1471-3290","authenticated-orcid":false,"given":"Diego","family":"Kauffmann-Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.lungcan.2026.109563_b0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.lungcan.2026.109563_b0010","doi-asserted-by":"crossref","unstructured":"Members of the IS, Prognostic Factors C, of the Advisory B, and Participating I, Rami-Porta R, Nishimura KK, Giroux DJ, Detterbeck F, Cardillo G, Edwards JG et al: The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groups in the Forthcoming (Ninth) Edition of the TNM Classification for Lung Cancer. Journal of Thoracic Oncology 2024, 19(7):1007-1027.","DOI":"10.1016\/j.jtho.2024.02.011"},{"issue":"2","key":"10.1016\/j.lungcan.2026.109563_b0015","doi-asserted-by":"crossref","DOI":"10.1183\/20734735.0039-2024","article-title":"Stage IV nonsmall cell lung cancer treatment: oligometastatic disease and disease progression, untangling the knot","volume":"20","author":"Tezvergil","year":"2024","journal-title":"Breathe"},{"issue":"4","key":"10.1016\/j.lungcan.2026.109563_b0020","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/resp.12496","article-title":"Clinical features and survival of lung cancer patients with pleural effusions","volume":"20","author":"Porcel","year":"2015","journal-title":"Respirology"},{"issue":"5","key":"10.1016\/j.lungcan.2026.109563_b0025","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejim.2007.09.014","article-title":"Prognostic significance of pleural fluid data in patients with malignant effusion","volume":"19","author":"Bielsa","year":"2008","journal-title":"Eur. J. Intern. Med."},{"issue":"5","key":"10.1016\/j.lungcan.2026.109563_b0030","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01254-2018","article-title":"Investigating unilateral pleural effusions: the role of cytology","volume":"52","author":"Arnold","year":"2018","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.lungcan.2026.109563_b0035","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.arbres.2013.11.007","article-title":"Etiology of pleural effusions: analysis of more than 3,000 consecutive thoracenteses","volume":"50","author":"Porcel","year":"2014","journal-title":"Arch. Bronconeumol."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109563_b0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12931-024-02684-7","article-title":"Malignant pleural effusion: current understanding and therapeutic approach","volume":"25","author":"Gonnelli","year":"2024","journal-title":"Respir. Res."},{"issue":"4","key":"10.1016\/j.lungcan.2026.109563_b0045","doi-asserted-by":"crossref","first-page":"507","DOI":"10.7326\/0003-4819-77-4-507","article-title":"Pleural effusions: the diagnostic separation of transudates and exudates","volume":"77","author":"Light","year":"1972","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.lungcan.2026.109563_b0050","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/01.mcp.0000128430.34150.80","article-title":"The separation of transudates and exudates with particular reference to the protein gradient","volume":"10","author":"Romero-Candeira","year":"2004","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"4","key":"10.1016\/j.lungcan.2026.109563_b0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250628","article-title":"Neutrophil-to-lymphocyte ratio in malignant pleural fluid: Prognostic significance","volume":"16","author":"Popowicz","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109563_b0060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1378\/chest.117.1.79","article-title":"Pleural fluid pH as a predictor of survival for patients with malignant pleural effusions","volume":"117","author":"Heffner","year":"2000","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.lungcan.2026.109563_b0065","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1136\/thoraxjnl-2014-205285","article-title":"Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score","volume":"69","author":"Clive","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.lungcan.2026.109563_b0070","first-page":"1","article-title":"Pleural fluid biomarkers for the diagnosis and management of malignant pleural effusions: a clinical review","author":"Santotoribio","year":"2025","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"4","key":"10.1016\/j.lungcan.2026.109563_b0075","first-page":"195","article-title":"Th1 and Th2 cytokine profiles in malignant pleural effusion","volume":"8","author":"Ghayumi","year":"2011","journal-title":"Iranian Journal of Immunology: IJI"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109563_b0080","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1038\/s41598-022-06685-8","article-title":"A meta-analysis of Th1 and Th2 cytokine profiles differentiating tuberculous from malignant pleural effusion","volume":"12","author":"Zeng","year":"2022","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.lungcan.2026.109563_b0085","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1378\/chest.128.6.4030","article-title":"T-helper type 1\/T-helper type 2 balance in malignant pleural effusions compared to tuberculous pleural effusions","volume":"128","author":"Okamoto","year":"2005","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.lungcan.2026.109563_b0090","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jtho.2016.09.137","article-title":"Systemic and Tumor Th1 and Th2 Inflammatory Profile and Macrophages in Lung Cancer: Influence of underlying Chronic respiratory Disease","volume":"12","author":"Mateu-Jimenez","year":"2017","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2026.109563_b0095","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.764596","article-title":"The Immune Landscape of Human Primary Lung Tumors is Th2 Skewed","volume":"12","author":"Frafjord","year":"2021","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.lungcan.2026.109563_b0100","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.3892\/ol.2017.6048","article-title":"IL-6 and TNF-\u03b1 promote metastasis of lung cancer by inducing epithelial-mesenchymal transition","volume":"13","author":"Shang","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.lungcan.2026.109563_b0105","doi-asserted-by":"crossref","unstructured":"Santoso A, Rasiha R, Munawwarah S, Mustang A: The Role of Interleukin 6 and Cyclooxygenase 2 In Progressivity and Metastatic Process in Andavce Non Small Cell Lung Cancer. European Respiratory Journal, 60(suppl 66):4316.","DOI":"10.1183\/13993003.congress-2022.4316"},{"issue":"6","key":"10.1016\/j.lungcan.2026.109563_b0110","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.chest.2016.01.001","article-title":"Longitudinal Measurement of Pleural Fluid Biochemistry and Cytokines in Malignant Pleural Effusions","volume":"149","author":"Thomas","year":"2016","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109563_b0115","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/LBR.0000000000000602","article-title":"Pleural Fluid Cytokine Levels at Baseline and over Time are Associated with Time to IPC Removal: an Exploratory Study","volume":"27","author":"Grosu","year":"2020","journal-title":"J Bronchology Interv Pulmonol"},{"issue":"4","key":"10.1016\/j.lungcan.2026.109563_b0120","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.21873\/invivo.12027","article-title":"Pleural Neutrophil-to-Lymphocyte Ratio May Be Associated with Early Disease Progression in Stage IV Non-small Cell Lung Cancer","volume":"34","author":"Lim","year":"2020","journal-title":"In Vivo"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109563_b0125","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1186\/s12885-017-3550-8","article-title":"Prognostic impact of a new score using neutrophil-to-lymphocyte ratios in the serum and malignant pleural effusion in lung cancer patients","volume":"17","author":"Lee","year":"2017","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.lungcan.2026.109563_b0130","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11121953","article-title":"Prognostic Immune Cell Profiling of Malignant Pleural Effusion patients by Computerized Immunohistochemical and Transcriptional Analysis","volume":"11","author":"Wu","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.lungcan.2026.109563_b0135","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S1470-2045(18)30294-8","article-title":"Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis","volume":"19","author":"Psallidas","year":"2018","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.lungcan.2026.109563_b0140","first-page":"1271","article-title":"Etiology and prognostic significance of eosinophilic pleural effusions","volume":"110","author":"Rubins","year":"1996","journal-title":"A Prospective Study. Chest"},{"issue":"2","key":"10.1016\/j.lungcan.2026.109563_b0145","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00262-021-02994-5","article-title":"Eosinophilic pleural effusion due to lung cancer has a better prognosis than non-eosinophilic malignant pleural effusion","volume":"71","author":"Takeuchi","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109563_b0150","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41698-024-00608-8","article-title":"CCL11\/CCR3-dependent eosinophilia alleviates malignant pleural effusions and improves prognosis","volume":"8","author":"Zhang","year":"2024","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.lungcan.2026.109563_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.672747","article-title":"Malignant Pleural Effusions-a Window into Local Anti-Tumor T Cell Immunity?","volume":"11","author":"Principe","year":"2021","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.lungcan.2026.109563_b0160","doi-asserted-by":"crossref","DOI":"10.3390\/biom15040491","article-title":"The Role of Eosinophils, Eosinophil-Related Cytokines and AI in predicting Immunotherapy Efficacy in NSCLC","volume":"15","author":"Omero","year":"2025","journal-title":"Biomolecules"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226006240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226006240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:25:30Z","timestamp":1791271530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500226006240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":32,"alternative-id":["S0169500226006240"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109563","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune signatures in NSCLC associated pleural effusions and implications for prognosis","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109563","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109563"}}